Outset Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-168.77	-172.8	-162.96	-131.94	-79.32	-85.46	Upgrade
Depreciation & Amortization	7.21	7.08	6.28	6.18	3.76	1.94	Upgrade
Share-Based Compensation	38.3	38.63	27.2	17.45	21.44	0.88	Upgrade
Other Operating Activities	-9.27	-4.29	-16.26	-21.96	-44.89	12.35	Upgrade
Operating Cash Flow	-132.53	-131.37	-145.73	-130.26	-99.02	-70.29	Upgrade
Capital Expenditures	-2.98	-3.44	-8.33	-3.11	-9.08	-3.29	Upgrade
Change in Investments	24.34	86.47	-57.97	-139.4	13.02	77.59	Upgrade
Investing Cash Flow	21.35	83.03	-66.3	-142.51	3.95	74.3	Upgrade
Share Issuance / Repurchase	7.24	10.43	8.04	160.15	255.99	0.44	Upgrade
Debt Issued / Paid	99.75	33.23	64.86	0	-1.36	-0.01	Upgrade
Other Financing Activities	-	-	-	-	131.05	-0.18	Upgrade
Financing Cash Flow	106.99	43.65	72.9	160.15	385.68	0.25	Upgrade
Net Cash Flow	-4.19	-4.7	-139.13	-112.62	290.61	4.25	Upgrade
Free Cash Flow	-135.51	-134.81	-154.05	-133.37	-108.09	-73.59	Upgrade
Free Cash Flow Margin	-108.34%	-103.40%	-133.52%	-129.99%	-216.47%	-488.03%	Upgrade
Free Cash Flow Per Share	-2.66	-2.72	-3.20	-2.93	-6.61	-85.76	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).